XML 69 R54.htm IDEA: XBRL DOCUMENT v3.19.2
Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Jul. 01, 2018
Jun. 30, 2019
Jul. 01, 2018
Sales by segment of business        
Sales to customers $ 20,562 $ 20,830 $ 40,583 $ 40,839
Percent Change (as a percent) (1.30%)   (0.60%)  
U.S.        
Sales by segment of business        
Sales to customers $ 10,403 10,640 $ 20,532 20,591
Percent Change (as a percent) (2.20%)   (0.30%)  
International        
Sales by segment of business        
Sales to customers $ 10,159 10,190 $ 20,051 20,248
Percent Change (as a percent) (0.30%)   (1.00%)  
CONSUMER        
Sales by segment of business        
Sales to customers $ 3,544 3,504 $ 6,862 6,902
Percent Change (as a percent) 1.20%   (0.60%)  
CONSUMER | U.S.        
Sales by segment of business        
Sales to customers $ 1,537 1,476 $ 2,975 2,912
Percent Change (as a percent) 4.10%   2.20%  
CONSUMER | International        
Sales by segment of business        
Sales to customers $ 2,007 2,028 $ 3,887 3,990
Percent Change (as a percent) (1.00%)   (2.60%)  
CONSUMER | Baby Care        
Sales by segment of business        
Sales to customers $ 443 456 $ 837 913
Percent Change (as a percent) (2.80%)   (8.40%)  
CONSUMER | Baby Care | U.S.        
Sales by segment of business        
Sales to customers $ 99 89 $ 186 186
Percent Change (as a percent) 11.50%   (0.20%)  
CONSUMER | Baby Care | International        
Sales by segment of business        
Sales to customers $ 344 367 $ 651 727
Percent Change (as a percent) (6.30%)   (10.50%)  
CONSUMER | Beauty        
Sales by segment of business        
Sales to customers $ 1,202 1,109 $ 2,292 2,193
Percent Change (as a percent) 8.40%   4.50%  
CONSUMER | Beauty | U.S.        
Sales by segment of business        
Sales to customers $ 663 637 $ 1,251 1,248
Percent Change (as a percent) 4.10%   0.30%  
CONSUMER | Beauty | International        
Sales by segment of business        
Sales to customers $ 539 472 $ 1,041 945
Percent Change (as a percent) 14.10%   10.10%  
CONSUMER | Oral Care        
Sales by segment of business        
Sales to customers $ 389 393 $ 756 772
Percent Change (as a percent) (1.10%)   (2.00%)  
CONSUMER | Oral Care | U.S.        
Sales by segment of business        
Sales to customers $ 155 157 $ 306 314
Percent Change (as a percent) (1.60%)   (2.50%)  
CONSUMER | Oral Care | International        
Sales by segment of business        
Sales to customers $ 234 236 $ 450 458
Percent Change (as a percent) (0.70%)   (1.70%)  
CONSUMER | OTC        
Sales by segment of business        
Sales to customers $ 1,064 1,066 $ 2,151 2,138
Percent Change (as a percent) (0.10%)   0.60%  
CONSUMER | OTC | U.S.        
Sales by segment of business        
Sales to customers $ 484 454 $ 991 919
Percent Change (as a percent) 6.60%   7.80%  
CONSUMER | OTC | International        
Sales by segment of business        
Sales to customers $ 580 612 $ 1,160 1,219
Percent Change (as a percent) (5.10%)   (4.90%)  
CONSUMER | Women's Health        
Sales by segment of business        
Sales to customers $ 253 280 $ 478 523
Percent Change (as a percent) (9.50%)   (8.50%)  
CONSUMER | Women's Health | U.S.        
Sales by segment of business        
Sales to customers $ 3 4 $ 6 7
Percent Change (as a percent) (10.30%)   (3.70%)  
CONSUMER | Women's Health | International        
Sales by segment of business        
Sales to customers $ 250 276 $ 472 516
Percent Change (as a percent) (9.50%)   (8.60%)  
CONSUMER | Wound Care/Other        
Sales by segment of business        
Sales to customers $ 193 200 $ 348 363
Percent Change (as a percent) (3.40%)   (4.00%)  
CONSUMER | Wound Care/Other | U.S.        
Sales by segment of business        
Sales to customers $ 132 135 $ 234 238
Percent Change (as a percent) (1.90%)   (1.50%)  
CONSUMER | Wound Care/Other | International        
Sales by segment of business        
Sales to customers $ 61 65 $ 114 125
Percent Change (as a percent) (6.40%)   (8.90%)  
PHARMACEUTICAL        
Sales by segment of business        
Sales to customers $ 10,529 10,354 $ 20,773 20,198
Percent Change (as a percent) 1.70%   2.80%  
PHARMACEUTICAL | U.S.        
Sales by segment of business        
Sales to customers $ 5,783 5,899 $ 11,365 11,253
Percent Change (as a percent) (2.00%)   1.00%  
PHARMACEUTICAL | International        
Sales by segment of business        
Sales to customers $ 4,746 4,455 $ 9,408 8,945
Percent Change (as a percent) 6.50%   5.20%  
PHARMACEUTICAL | Immunology        
Sales by segment of business        
Sales to customers $ 3,466 3,338 $ 6,717 6,380
Percent Change (as a percent) 3.80%   5.30%  
PHARMACEUTICAL | Immunology | U.S.        
Sales by segment of business        
Sales to customers $ 2,379 2,317 $ 4,542 4,317
Percent Change (as a percent) 2.70%   5.20%  
PHARMACEUTICAL | Immunology | International        
Sales by segment of business        
Sales to customers $ 1,087 1,021 $ 2,175 2,063
Percent Change (as a percent) 6.30%   5.40%  
PHARMACEUTICAL | Immunology | REMICADE®        
Sales by segment of business        
Sales to customers $ 1,107 1,320 $ 2,209 2,709
Percent Change (as a percent) (16.20%)   (18.50%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S.        
Sales by segment of business        
Sales to customers $ 801 918 $ 1,575 1,834
Percent Change (as a percent) (12.70%)   (14.10%)  
PHARMACEUTICAL | Immunology | REMICADE® | U.S. Exports        
Sales by segment of business        
Sales to customers $ 62 104 $ 138 246
Percent Change (as a percent) (40.30%)   (43.90%)  
PHARMACEUTICAL | Immunology | REMICADE® | International        
Sales by segment of business        
Sales to customers $ 244 298 $ 496 629
Percent Change (as a percent) (18.50%)   (21.20%)  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA®        
Sales by segment of business        
Sales to customers $ 563 548 $ 1,087 1,066
Percent Change (as a percent) 2.70%   1.90%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | U.S.        
Sales by segment of business        
Sales to customers $ 281 274 $ 544 498
Percent Change (as a percent) 2.70%   9.10%  
PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA® | International        
Sales by segment of business        
Sales to customers $ 282 274 $ 543 568
Percent Change (as a percent) 2.70%   (4.40%)  
PHARMACEUTICAL | Immunology | STELARA®        
Sales by segment of business        
Sales to customers $ 1,558 1,341 $ 2,963 2,402
Percent Change (as a percent) 16.10%   23.30%  
PHARMACEUTICAL | Immunology | STELARA® | U.S.        
Sales by segment of business        
Sales to customers $ 1,058 919 $ 1,940 1,571
Percent Change (as a percent) 15.20%   23.50%  
PHARMACEUTICAL | Immunology | STELARA® | International        
Sales by segment of business        
Sales to customers $ 499 422 $ 1,022 831
Percent Change (as a percent) 18.10%   23.00%  
PHARMACEUTICAL | Immunology | TREMFYA®        
Sales by segment of business        
Sales to customers $ 235 126 $ 452 198
Percent Change (as a percent) 86.50%      
PHARMACEUTICAL | Immunology | TREMFYA® | U.S.        
Sales by segment of business        
Sales to customers $ 176 102 344 168
Percent Change (as a percent) 72.30%      
PHARMACEUTICAL | Immunology | TREMFYA® | International        
Sales by segment of business        
Sales to customers $ 59 24 108 30
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY        
Sales by segment of business        
Sales to customers $ 3 3 $ 6 5
Percent Change (as a percent) 27.70%   23.60%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International        
Sales by segment of business        
Sales to customers $ 3 3 $ 6 5
Percent Change (as a percent) 27.70%   23.60%  
PHARMACEUTICAL | Infectious Diseases        
Sales by segment of business        
Sales to customers $ 862 849 $ 1,708 1,679
Percent Change (as a percent) 1.50%   1.70%  
PHARMACEUTICAL | Infectious Diseases | U.S.        
Sales by segment of business        
Sales to customers $ 387 328 $ 744 661
Percent Change (as a percent) 17.80%   12.50%  
PHARMACEUTICAL | Infectious Diseases | International        
Sales by segment of business        
Sales to customers $ 475 521 $ 964 1,018
Percent Change (as a percent) (8.70%)   (5.30%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine        
Sales by segment of business        
Sales to customers $ 210 211 $ 421 421
Percent Change (as a percent) (0.60%)   0.10%  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | U.S.        
Sales by segment of business        
Sales to customers $ 12 15 $ 24 29
Percent Change (as a percent) (15.80%)   (17.30%)  
PHARMACEUTICAL | Infectious Diseases | EDURANT® / rilpivirine | International        
Sales by segment of business        
Sales to customers $ 198 196 $ 397 392
Percent Change (as a percent) 0.50%   1.40%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA®        
Sales by segment of business        
Sales to customers $ 535 492 $ 1,058 970
Percent Change (as a percent) 8.70%   9.10%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | U.S.        
Sales by segment of business        
Sales to customers $ 344 277 $ 659 550
Percent Change (as a percent) 24.20%   19.90%  
PHARMACEUTICAL | Infectious Diseases | PREZISTA® / PREZCOBIX® / REZOLSTA® / SYMTUZA® | International        
Sales by segment of business        
Sales to customers $ 191 215 $ 399 420
Percent Change (as a percent) (11.10%)   (5.00%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES        
Sales by segment of business        
Sales to customers $ 117 146 $ 229 288
Percent Change (as a percent) (19.70%)   (20.70%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.        
Sales by segment of business        
Sales to customers $ 31 36 $ 61 82
Percent Change (as a percent) (16.60%)   (26.00%)  
PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International        
Sales by segment of business        
Sales to customers $ 86 110 $ 168 206
Percent Change (as a percent) (20.80%)   (18.60%)  
PHARMACEUTICAL | Neuroscience        
Sales by segment of business        
Sales to customers $ 1,538 1,528 $ 3,167 3,087
Percent Change (as a percent) 0.60%   2.60%  
PHARMACEUTICAL | Neuroscience | U.S.        
Sales by segment of business        
Sales to customers $ 664 639 $ 1,387 1,263
Percent Change (as a percent) 3.80%   9.80%  
PHARMACEUTICAL | Neuroscience | International        
Sales by segment of business        
Sales to customers $ 875 889 $ 1,780 1,824
Percent Change (as a percent) (1.60%)   (2.40%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate        
Sales by segment of business        
Sales to customers $ 137 183 $ 351 356
Percent Change (as a percent) (25.20%)   (1.60%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | U.S.        
Sales by segment of business        
Sales to customers $ 15 68 $ 112 134
Percent Change (as a percent) (78.60%)   (16.40%)  
PHARMACEUTICAL | Neuroscience | CONCERTA® / methylphenidate | International        
Sales by segment of business        
Sales to customers $ 123 115 $ 239 222
Percent Change (as a percent) 6.20%   7.30%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA®        
Sales by segment of business        
Sales to customers $ 818 720 $ 1,608 1,416
Percent Change (as a percent) 13.60%   13.60%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | U.S.        
Sales by segment of business        
Sales to customers $ 506 438 $ 989 838
Percent Change (as a percent) 15.60%   18.10%  
PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA® / XEPLION® / INVEGA TRINZA® / TREVICTA® | International        
Sales by segment of business        
Sales to customers $ 312 282 $ 619 578
Percent Change (as a percent) 10.40%   7.00%  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA®        
Sales by segment of business        
Sales to customers $ 182 188 $ 361 384
Percent Change (as a percent) (3.40%)   (6.20%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | U.S.        
Sales by segment of business        
Sales to customers $ 81 80 $ 158 162
Percent Change (as a percent) 0.80%   (3.00%)  
PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA® | International        
Sales by segment of business        
Sales to customers $ 101 108 $ 203 222
Percent Change (as a percent) (6.50%)   (8.40%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE        
Sales by segment of business        
Sales to customers $ 401 437 $ 847 931
Percent Change (as a percent) (8.10%)   (8.90%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.        
Sales by segment of business        
Sales to customers $ 62 53 $ 128 129
Percent Change (as a percent) 16.10%   (0.40%)  
PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International        
Sales by segment of business        
Sales to customers $ 340 384 $ 719 802
Percent Change (as a percent) (11.50%)   (10.30%)  
PHARMACEUTICAL | Oncology        
Sales by segment of business        
Sales to customers $ 2,697 2,456 $ 5,215 4,767
Percent Change (as a percent) 9.80%   9.40%  
PHARMACEUTICAL | Oncology | U.S.        
Sales by segment of business        
Sales to customers $ 1,013 1,085 $ 1,975 2,018
Percent Change (as a percent) (6.60%)   (2.10%)  
PHARMACEUTICAL | Oncology | International        
Sales by segment of business        
Sales to customers $ 1,684 1,371 $ 3,240 2,749
Percent Change (as a percent) 22.80%   17.90%  
PHARMACEUTICAL | Oncology | DARZALEX®        
Sales by segment of business        
Sales to customers $ 774 511 $ 1,403 943
Percent Change (as a percent) 51.60%   48.80%  
PHARMACEUTICAL | Oncology | DARZALEX® | U.S.        
Sales by segment of business        
Sales to customers $ 369 298 $ 721 562
Percent Change (as a percent) 24.40%   28.50%  
PHARMACEUTICAL | Oncology | DARZALEX® | International        
Sales by segment of business        
Sales to customers $ 405 213 $ 682 381
Percent Change (as a percent) 89.50%   78.70%  
PHARMACEUTICAL | Oncology | IMBRUVICA®        
Sales by segment of business        
Sales to customers $ 831 620 $ 1,615 1,207
Percent Change (as a percent) 34.10%   33.80%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | U.S.        
Sales by segment of business        
Sales to customers $ 367 250 $ 716 477
Percent Change (as a percent) 47.00%   50.20%  
PHARMACEUTICAL | Oncology | IMBRUVICA® | International        
Sales by segment of business        
Sales to customers $ 463 370 $ 898 730
Percent Change (as a percent) 25.30%   23.10%  
PHARMACEUTICAL | Oncology | VELCADE®        
Sales by segment of business        
Sales to customers $ 224 280 $ 487 593
Percent Change (as a percent) (20.10%)   (17.90%)  
PHARMACEUTICAL | Oncology | VELCADE® | U.S.        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Oncology | VELCADE® | International        
Sales by segment of business        
Sales to customers $ 224 280 $ 487 593
Percent Change (as a percent) (20.10%)   (17.90%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate        
Sales by segment of business        
Sales to customers $ 698 909 $ 1,377 1,754
Percent Change (as a percent) (23.30%)   (21.50%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | U.S.        
Sales by segment of business        
Sales to customers $ 198 486 $ 383 893
Percent Change (as a percent) (59.40%)   (57.10%)  
PHARMACEUTICAL | Oncology | ZYTIGA® / abiraterone acetate | International        
Sales by segment of business        
Sales to customers $ 500 423 $ 994 861
Percent Change (as a percent) 18.00%   15.40%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY        
Sales by segment of business        
Sales to customers $ 170 136 $ 333 270
Percent Change (as a percent) 24.70%   23.20%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.        
Sales by segment of business        
Sales to customers $ 78 51 $ 154 86
Percent Change (as a percent) 50.50%   77.70%  
PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International        
Sales by segment of business        
Sales to customers $ 92 85 $ 179 184
Percent Change (as a percent) 8.80%   (2.50%)  
PHARMACEUTICAL | Pulmonary Hypertension        
Sales by segment of business        
Sales to customers $ 690 665 $ 1,346 1,250
Percent Change (as a percent) 3.80%   7.70%  
PHARMACEUTICAL | Pulmonary Hypertension | U.S.        
Sales by segment of business        
Sales to customers $ 439 429 $ 869 790
Percent Change (as a percent) 2.20%   10.00%  
PHARMACEUTICAL | Pulmonary Hypertension | International        
Sales by segment of business        
Sales to customers $ 251 236 $ 477 460
Percent Change (as a percent) 6.70%   3.70%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT®        
Sales by segment of business        
Sales to customers $ 348 311 $ 654 582
Percent Change (as a percent) 12.30%   12.50%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | U.S.        
Sales by segment of business        
Sales to customers $ 203 180 $ 375 329
Percent Change (as a percent) 12.80%   14.20%  
PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT® | International        
Sales by segment of business        
Sales to customers $ 146 131 $ 279 253
Percent Change (as a percent) 11.50%   10.30%  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER®        
Sales by segment of business        
Sales to customers $ 103 143 $ 220 283
Percent Change (as a percent) (28.00%)   (22.40%)  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | U.S.        
Sales by segment of business        
Sales to customers $ 41 71 $ 102 139
Percent Change (as a percent) (41.80%)   (26.30%)  
PHARMACEUTICAL | Pulmonary Hypertension | TRACLEER® | International        
Sales by segment of business        
Sales to customers $ 62 72 $ 118 144
Percent Change (as a percent) (14.50%)   (18.70%)  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI®        
Sales by segment of business        
Sales to customers $ 203 171 $ 401 311
Percent Change (as a percent) 18.20%   28.70%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | U.S.        
Sales by segment of business        
Sales to customers $ 175 155 $ 351 279
Percent Change (as a percent) 13.40%   25.90%  
PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI® | International        
Sales by segment of business        
Sales to customers $ 28 16 $ 50 32
Percent Change (as a percent) 62.50%   53.10%  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER        
Sales by segment of business        
Sales to customers $ 37 40 $ 72 74
Percent Change (as a percent) (9.60%)   (3.40%)  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 20 23 $ 41 43
Percent Change (as a percent) (18.20%)   (8.40%)  
PHARMACEUTICAL | Pulmonary Hypertension | OTHER | International        
Sales by segment of business        
Sales to customers $ 16 17 $ 31 31
Percent Change (as a percent) 3.70%   4.10%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other        
Sales by segment of business        
Sales to customers $ 1,275 1,518 $ 2,620 3,035
Percent Change (as a percent) (16.00%)   (13.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.        
Sales by segment of business        
Sales to customers $ 902 1,101 $ 1,849 2,204
Percent Change (as a percent) (18.10%)   (16.10%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International        
Sales by segment of business        
Sales to customers $ 373 417 $ 771 831
Percent Change (as a percent) (10.50%)   (7.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO®        
Sales by segment of business        
Sales to customers $ 549 679 $ 1,091 1,257
Percent Change (as a percent) (19.20%)   (13.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | U.S.        
Sales by segment of business        
Sales to customers $ 549 679 $ 1,091 1,257
Percent Change (as a percent) (19.20%)   (13.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO® | International        
Sales by segment of business        
Sales to customers $ 0 0 $ 0 0
Percent Change (as a percent) 0.00%   0.00%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET®        
Sales by segment of business        
Sales to customers $ 177 215 $ 379 463
Percent Change (as a percent) (17.90%)   (18.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | U.S.        
Sales by segment of business        
Sales to customers $ 132 169 $ 286 373
Percent Change (as a percent) (21.20%)   (23.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA® / INVOKAMET® | International        
Sales by segment of business        
Sales to customers $ 43 46 $ 92 90
Percent Change (as a percent) (6.00%)   2.60%  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX®        
Sales by segment of business        
Sales to customers $ 183 236 $ 409 512
Percent Change (as a percent) (22.70%)   (20.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | U.S.        
Sales by segment of business        
Sales to customers $ 113 156 $ 261 345
Percent Change (as a percent) (27.50%)   (24.30%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT® / EPREX® | International        
Sales by segment of business        
Sales to customers $ 70 80 $ 148 167
Percent Change (as a percent) (13.40%)   (11.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER        
Sales by segment of business        
Sales to customers $ 368 388 $ 742 803
Percent Change (as a percent) (5.50%)   (7.70%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 107 97 $ 211 229
Percent Change (as a percent) 9.30%   (8.20%)  
PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER | International        
Sales by segment of business        
Sales to customers $ 260 291 $ 531 574
Percent Change (as a percent) (10.50%)   (7.50%)  
MEDICAL DEVICES        
Sales by segment of business        
Sales to customers $ 6,489 6,972 $ 12,948 13,739
Percent Change (as a percent) (6.90%)   (5.70%)  
MEDICAL DEVICES | U.S.        
Sales by segment of business        
Sales to customers $ 3,083 3,265 $ 6,192 6,426
Percent Change (as a percent) (5.60%)   (3.60%)  
MEDICAL DEVICES | International        
Sales by segment of business        
Sales to customers $ 3,406 3,707 $ 6,756 7,313
Percent Change (as a percent) (8.10%)   (7.60%)  
MEDICAL DEVICES | Diabetes Care        
Sales by segment of business        
Sales to customers $ 0 355 $ 0 694
MEDICAL DEVICES | Diabetes Care | U.S.        
Sales by segment of business        
Sales to customers 0 129 0 246
MEDICAL DEVICES | Diabetes Care | International        
Sales by segment of business        
Sales to customers 0 226 0 448
MEDICAL DEVICES | Interventional Solutions        
Sales by segment of business        
Sales to customers $ 750 667 $ 1,482 1,307
Percent Change (as a percent) 12.60%   13.40%  
MEDICAL DEVICES | Interventional Solutions | U.S.        
Sales by segment of business        
Sales to customers $ 366 323 $ 709 627
Percent Change (as a percent) 13.70%   13.20%  
MEDICAL DEVICES | Interventional Solutions | International        
Sales by segment of business        
Sales to customers $ 385 344 $ 774 680
Percent Change (as a percent) 11.60%   13.70%  
MEDICAL DEVICES | Orthopaedics        
Sales by segment of business        
Sales to customers $ 2,224 2,262 $ 4,428 4,512
Percent Change (as a percent) (1.60%)   (1.90%)  
MEDICAL DEVICES | Orthopaedics | U.S.        
Sales by segment of business        
Sales to customers $ 1,331 1,332 $ 2,649 2,639
Percent Change (as a percent) (0.10%)   0.40%  
MEDICAL DEVICES | Orthopaedics | International        
Sales by segment of business        
Sales to customers $ 894 930 $ 1,779 1,873
Percent Change (as a percent) (3.80%)   (5.00%)  
MEDICAL DEVICES | Orthopaedics | HIPS        
Sales by segment of business        
Sales to customers $ 364 360 $ 725 723
Percent Change (as a percent) 0.90%   0.30%  
MEDICAL DEVICES | Orthopaedics | HIPS | U.S.        
Sales by segment of business        
Sales to customers $ 216 211 $ 429 420
Percent Change (as a percent) 2.10%   2.10%  
MEDICAL DEVICES | Orthopaedics | HIPS | International        
Sales by segment of business        
Sales to customers $ 147 149 $ 295 303
Percent Change (as a percent) (0.70%)   (2.30%)  
MEDICAL DEVICES | Orthopaedics | KNEES        
Sales by segment of business        
Sales to customers $ 372 382 $ 741 769
Percent Change (as a percent) (2.80%)   (3.70%)  
MEDICAL DEVICES | Orthopaedics | KNEES | U.S.        
Sales by segment of business        
Sales to customers $ 218 229 $ 441 457
Percent Change (as a percent) (4.80%)   (3.50%)  
MEDICAL DEVICES | Orthopaedics | KNEES | International        
Sales by segment of business        
Sales to customers $ 153 153 $ 299 312
Percent Change (as a percent) 0.40%   (4.00%)  
MEDICAL DEVICES | Orthopaedics | TRAUMA        
Sales by segment of business        
Sales to customers $ 672 675 $ 1,357 1,371
Percent Change (as a percent) (0.60%)   (1.00%)  
MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.        
Sales by segment of business        
Sales to customers $ 407 394 $ 824 801
Percent Change (as a percent) 3.30%   2.90%  
MEDICAL DEVICES | Orthopaedics | TRAUMA | International        
Sales by segment of business        
Sales to customers $ 265 281 $ 533 570
Percent Change (as a percent) (5.90%)   (6.50%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER        
Sales by segment of business        
Sales to customers $ 818 845 $ 1,606 1,649
Percent Change (as a percent) (3.10%)   (2.60%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 490 498 $ 955 961
Percent Change (as a percent) (1.50%)   (0.60%)  
MEDICAL DEVICES | Orthopaedics | SPINE & OTHER | International        
Sales by segment of business        
Sales to customers $ 328 347 $ 651 688
Percent Change (as a percent) (5.30%)   (5.40%)  
MEDICAL DEVICES | Surgery        
Sales by segment of business        
Sales to customers $ 2,353 2,515 $ 4,748 4,938
Percent Change (as a percent) (6.50%)   (3.90%)  
MEDICAL DEVICES | Surgery | U.S.        
Sales by segment of business        
Sales to customers $ 926 1,022 $ 1,927 2,015
Percent Change (as a percent) (9.50%)   (4.40%)  
MEDICAL DEVICES | Surgery | International        
Sales by segment of business        
Sales to customers $ 1,427 1,493 $ 2,821 2,923
Percent Change (as a percent) (4.40%)   (3.50%)  
MEDICAL DEVICES | Surgery | ADVANCED        
Sales by segment of business        
Sales to customers $ 1,029 1,005 $ 2,009 1,971
Percent Change (as a percent) 2.30%   1.90%  
MEDICAL DEVICES | Surgery | ADVANCED | U.S.        
Sales by segment of business        
Sales to customers $ 396 402 $ 800 795
Percent Change (as a percent) (1.70%)   0.60%  
MEDICAL DEVICES | Surgery | ADVANCED | International        
Sales by segment of business        
Sales to customers $ 633 603 $ 1,209 1,176
Percent Change (as a percent) 5.00%   2.80%  
MEDICAL DEVICES | Surgery | GENERAL        
Sales by segment of business        
Sales to customers $ 1,119 1,169 $ 2,208 2,296
Percent Change (as a percent) (4.30%)   (3.90%)  
MEDICAL DEVICES | Surgery | GENERAL | U.S.        
Sales by segment of business        
Sales to customers $ 443 436 $ 868 859
Percent Change (as a percent) 1.60%   1.00%  
MEDICAL DEVICES | Surgery | GENERAL | International        
Sales by segment of business        
Sales to customers $ 674 733 $ 1,339 1,437
Percent Change (as a percent) (7.90%)   (6.80%)  
MEDICAL DEVICES | Surgery | SPECIALTY        
Sales by segment of business        
Sales to customers $ 206 341 $ 531 671
Percent Change (as a percent) (39.60%)   (20.80%)  
MEDICAL DEVICES | Surgery | SPECIALTY | U.S.        
Sales by segment of business        
Sales to customers $ 87 184 $ 259 361
Percent Change (as a percent) (53.10%)   (28.30%)  
MEDICAL DEVICES | Surgery | SPECIALTY | International        
Sales by segment of business        
Sales to customers $ 120 157 $ 273 310
Percent Change (as a percent) (23.70%)   (12.10%)  
MEDICAL DEVICES | Vision        
Sales by segment of business        
Sales to customers $ 1,161 1,173 $ 2,290 2,288
Percent Change (as a percent) (1.00%)   0.10%  
MEDICAL DEVICES | Vision | U.S.        
Sales by segment of business        
Sales to customers $ 461 459 $ 907 899
Percent Change (as a percent) 0.40%   1.00%  
MEDICAL DEVICES | Vision | International        
Sales by segment of business        
Sales to customers $ 701 714 $ 1,383 1,389
Percent Change (as a percent) (2.00%)   (0.50%)  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER        
Sales by segment of business        
Sales to customers $ 842 844 $ 1,666 1,651
Percent Change (as a percent) (0.30%)   0.90%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.        
Sales by segment of business        
Sales to customers $ 333 320 $ 654 629
Percent Change (as a percent) 3.90%   4.00%  
MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International        
Sales by segment of business        
Sales to customers $ 509 524 $ 1,011 1,022
Percent Change (as a percent) (2.90%)   (1.00%)  
MEDICAL DEVICES | Vision | SURGICAL        
Sales by segment of business        
Sales to customers $ 319 329 $ 624 637
Percent Change (as a percent) (2.80%)   (2.00%)  
MEDICAL DEVICES | Vision | SURGICAL | U.S.        
Sales by segment of business        
Sales to customers $ 128 139 $ 253 270
Percent Change (as a percent) (7.70%)   (6.10%)  
MEDICAL DEVICES | Vision | SURGICAL | International        
Sales by segment of business        
Sales to customers $ 191 $ 190 $ 371 $ 367
Percent Change (as a percent) 0.70%   1.00%